Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival.

By P. Morgan, P. H. van der Graaf, J. Arrowsmith, D. Feltner, Kira S Drummond, C. Wegner, S. Street. Drug Discovery Today, 2012

636 citations recorded by the source corpus.

Subfields: Computational Theory and Mathematics, Immunology, Virology

View Paper: https://www.semanticscholar.org/paper/5a0994278a23e940ab4418222f9f7b5a5e292ec7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Computational Theory and Mathematics

1. Daniela Sciaky
2. Robin J. Johnson
3. Allan Peter Davis
4. Thomas C. Wiegers
5. Carolyn J. Mattingly
6. Christopher R'e
7. Paroma Varma

Citations in the corpus

• A CTD–Pfizer collaboration: manual curation of 88 000 scientific articles text mined for drug–disease and drug–phenotype interactions (2013, background): “A critical feature of drug development is pharmaceutical compound survival, wherein new molecular entities are allowed to continue through clinical development by demonstrating positive efficacy as well as safety (4).”